Blue Shield of California (BSC) announced that it will no longer use CVS Caremark as its pharmacy benefit manager (PBM). Instead, the health plan is implementing a first-of-its-kind pharmacy care model that is expected to save up to $500 million in annual drug costs. Does this signal the start of a consequential shift in the PBM industry? Advisory Board's Chloe Bakst and Solomon Banjo share three predictions.  

According to a new report from KFF, the United States pays significantly more for weight-loss drugs, including Ozempic and Wegovy, than peer nations, with U.S. prices sometimes being 10 times higher. See the findings on our interactive charts.

Pfizer and Moderna have both separately announced that their updated COVID-19 vaccines, which are slated to become available this fall, are effective against new coronavirus variants that are now circulating, including EG.5.1, nicknamed "Eris," and FL.1.5.1, nicknamed "Fornax."

Binge drinking and marijuana use among adults ages 35 to 50 have hit record highs, in today's bite-sized hospital and health industry news from Georgia, Michigan, and Oregon.

What you need to know about new Wegovy trial results, the latest long COVID symptom, and more.